ZBTB34 and thyroid gland carcinoma: However, the expression of ZBTB34 in the tumor tissues of BRCA (Breast invasive carcinoma) (P<0.001), COAD (Colon adenocarcinoma) (P<0.001), KICH (Kidney chromophobe) (P<0.01), LUAD (Lung adenocarcinoma) (P<0.001), LUSC (Lung squamous cell carcinoma) (P<0.05), SKCM (Skin Cutaneous Melanoma) (P<0.001), THCA (Thyroid carcinoma) (P<0.01), and UCEC (Uterine Corpus Endometrial Carcinoma) (P<0.001) is significantly decreased in comparison with the control tissues (Figure 1A).